Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
KemPharm, Inc. - Common Stock
(NQ:
KMPH
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 28, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
5.690 (8)
Ask (Size)
6.000 (20)
Prev. Close
5.810
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
33,932,639
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CORRECTION – KemPharm Announces Corporate Name Change to Zevra Therapeutics
February 22, 2023
From
KemPharm
Via
GlobeNewswire
KemPharm Announces Corporate Name Change to Zevra Therapeutics
February 22, 2023
From
KemPharm
Via
GlobeNewswire
Performance
More News
Read More
This Rare Disease Focused Stock Pipeline Is Underappreciated, Analyst Initiating Coverage Says
↗
November 17, 2022
Via
Benzinga
KemPharm's Earnings: A Preview
↗
November 08, 2022
Via
Benzinga
KemPharm's Lead Prodrug Shows Favorable Safety Profile For Rare Sleeping Disorder
↗
September 28, 2022
Via
Benzinga
Recap: KemPharm Q2 Earnings
↗
August 11, 2022
Via
Benzinga
KemPharm Acquires Battered Orphazyme's Arimoclomol Program For $13M
↗
May 16, 2022
Via
Benzinga
KemPharm's SDX Higher Dose Shows Potential Against Sleep Disorders
↗
March 21, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
↗
November 17, 2022
Via
Benzinga
US Stocks Turn Lower; Nasdaq Drops Over 100 Points
↗
September 15, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022
↗
September 15, 2022
Via
Benzinga
Apple To $220? Here Are 5 Other Price Target Changes For Wednesday
↗
August 17, 2022
Via
Benzinga
Recap: KemPharm Q1 Earnings
↗
May 12, 2022
Via
Benzinga
Earnings Preview For KemPharm
↗
May 11, 2022
Via
Benzinga
The Technology Helping Existing FDA-Approved Drugs Target More Effectively
↗
May 03, 2022
Via
Benzinga
Benzinga Announces This Week's All Access Guests
↗
April 28, 2022
Via
Benzinga
26 Stocks Moving in Monday's Pre-Market Session
↗
April 25, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
March 31, 2022
Via
Benzinga
Earnings Scheduled For March 30, 2022
↗
March 30, 2022
Via
Benzinga
KemPharm To Develop KP1077 As Lead SDX Candidate For Chronic Sleep Disorder
↗
January 20, 2022
Via
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
↗
March 27, 2022
Via
Benzinga
38 Stocks Moving In Monday's Mid-Day Session
↗
December 20, 2021
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
February 16, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022
↗
January 31, 2022
Via
Benzinga
65 Biggest Movers From Yesterday
↗
December 21, 2021
Via
Benzinga
Frequently Asked Questions
Is KemPharm, Inc. - Common Stock publicly traded?
Yes, KemPharm, Inc. - Common Stock is publicly traded.
What exchange does KemPharm, Inc. - Common Stock trade on?
KemPharm, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for KemPharm, Inc. - Common Stock?
The ticker symbol for KemPharm, Inc. - Common Stock is KMPH on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.